AstraZeneca-Oxford Covid Vaccine on Track for Year End, CEO Says
Representational: A heath worker draws the ‘Gam-COVID-Vac’, also known as ‘Sputnik V’, Covid-19 vaccine, from a vial during a post-registration phase trial in Moscow, Russia. (Photographer: Andrey Rudakov/Bloomberg)

AstraZeneca-Oxford Covid Vaccine on Track for Year End, CEO Says

(Bloomberg) -- AstraZeneca Plc’s coronavirus shot could be ready for large-scale vaccinations as early as this year, Chief Executive Officer Pascal Soriot said, dismissing reports of delays and pro...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.